What is the significance of this filing being an amendment (10-Q/A)?

An amendment (10-Q/A) indicates that McKesson Corporation has revised or added information to its original quarterly report. Investors should carefully review the amended sections to understand any changes in financial results, disclosures, or management's commentary compared to the initial filing.

What are the key financial metrics investors should look for in this filing?

While specific figures are not in the excerpt, investors typically examine revenue, net income (profitability), earnings per share (EPS), cash flow from operations, and the company's balance sheet (assets, liabilities, and equity) to gauge McKesson's financial performance and health.

What does McKesson Corporation do?

McKesson Corporation is a major distributor of pharmaceuticals and health care products, playing a critical role in the healthcare supply chain.

Where can I find the detailed financial information for this period?

The detailed financial statements, including the balance sheet, income statement, and cash flow statement, along with the Management's Discussion and Analysis (MD&A), would be contained within the full 10-Q/A document filed with the SEC. This excerpt only provides metadata about the filing.

MCK 10-Q Filed May 22, 1995

Summary

McKesson Corporation's (MCK) amended 10-Q filing for the period ending December 30, 1994, provides a snapshot of its financial standing as of that date. As a major distributor of pharmaceuticals and health care products, the company's performance is closely watched by investors for insights into the broader healthcare supply chain. This filing, being an amendment, suggests potential revisions or additions to previously reported information, which investors should review carefully to understand any updated financial positions or operational disclosures. While specific financial figures are not detailed in the provided document excerpt, the filing indicates McKesson's ongoing operations in the healthcare sector. Investors would typically look for information regarding revenue growth, profitability, debt levels, and cash flow to assess the company's financial health and future prospects. The amendment might also contain updated risk factors, legal proceedings, or management discussion and analysis (MD&A) that could impact the investment thesis.

Key Highlights

1This filing is an amendment (10-Q/A) to McKesson Corporation's Quarterly Report.
2The report covers the period ending December 30, 1994.
3The original filing date for this amendment was May 21, 1995.
4McKesson Corporation operates in the pharmaceutical and healthcare product distribution industry.
5As an amendment, this filing may contain revised or supplementary financial and operational information.
6Investors should consult the full filing for detailed financial statements and management's discussion.

MCKESSON CORP Quarterly Report (Amendment) for Q3 Ended Dec 31, 1994

Summary

Key Highlights

Frequently Asked Questions